<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04184349</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-19-0760</org_study_id>
    <nct_id>NCT04184349</nct_id>
  </id_info>
  <brief_title>Truncal Ultrasound Guided Regional Anesthesia for Implantation and Revision of Automatic Implantable Cardioverter Defibrillators (AICDs) and Pacemakers in Pediatric Patients</brief_title>
  <official_title>Truncal Ultrasound Guided Regional Anesthesia for Implantation and Revision of AICDs and Pacemakers in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy and safety of truncal blocks for&#xD;
      pacemaker and Automatic Implantable Cardioverter Defibrillator implantation in children and&#xD;
      to prospectively evaluate whether there is a decrease in amount of narcotic medications need&#xD;
      and track complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total narcotic dose in milligram morphine equivalents (MME) needed</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain as measured by the visual analog scale (VAS) pain score</measure>
    <time_frame>up to 1.5 hours post procedure in post anesthesia care unit (PACU)</time_frame>
    <description>VAS pain scale is a range of scores from 0-100. A higher score indicates greater pain intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with the incidence of pruritis</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with the incidence of nausea/vomiting</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with respiratory depression</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with local anesthetic toxicity</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with incidence of pneumothorax</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Analgesia After Pacemaker</condition>
  <condition>AICDS Implantation Pediatrics</condition>
  <arm_group>
    <arm_group_label>Local Anesthetic (LA Group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LA group</intervention_name>
    <description>In the LA group, only the local anesthetic infiltration will be performed by injecting the numbing medicine ropivacaine into the surgical site.</description>
    <arm_group_label>Local Anesthetic (LA Group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>B Group</intervention_name>
    <description>In the B Group,pectoral (PECS) and transversus thoracic plane(TTP) blocks will be performed by injecting the numbing medicine ropivacaine near the nerves.</description>
    <arm_group_label>B group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing implantation or revision of pacemaker or AICD in the pediatric&#xD;
             cath lab&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  parent or patient refusal&#xD;
&#xD;
          -  use of narcotic medications prior to procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olga Pewelek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olga Pewelek, MD</last_name>
    <phone>7135006227</phone>
    <email>Olga.I.Lyuksyutova@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kelbie J Kerr</last_name>
    <phone>225-715-1371</phone>
    <email>Kelbie.J.Kerr@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Pewelek, MD</last_name>
      <phone>713-500-6227</phone>
      <email>Olga.I.Lyuksyutova@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kelbie J Kerr</last_name>
      <phone>225-715-1371</phone>
      <email>Kelbie.J.Kerr@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 7, 2019</study_first_submitted>
  <study_first_submitted_qc>December 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>November 13, 2021</last_update_submitted>
  <last_update_submitted_qc>November 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Olga Pawelek</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>pacemaker</keyword>
  <keyword>AICDS</keyword>
  <keyword>regional anesthesia</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

